Evaluating the Health Impact of Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease: Insights from a Contemporary, Prospective Population-Based Study of Hong Kong
Grant Data
Project Title
Evaluating the Health Impact of Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease: Insights from a Contemporary, Prospective Population-Based Study of Hong Kong
Principal Investigator
Professor Lee, Chi Ho Paul
(Principal Investigator (PI))
Co-Investigator(s)
Dr. Woo Yu Cho
(Co-Investigator)
Emeritus Professor Lam Karen Siu Ling
(Co-Investigator)
Professor Mak Lung Yi
(Co-Investigator)
Miss Fong Ho Yi
(Co-Investigator)
Professor Lui Tak Wai David
(Co-Investigator)
Duration
36
Start Date
2024-09-01
Amount
1462156
Conference Title
Evaluating the Health Impact of Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease: Insights from a Contemporary, Prospective Population-Based Study of Hong Kong
Keywords
MAFLD, Diabetes, Cardiovascular Disease, Liver Fibrosis, Population-based Study
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
21222691
Grant Type
Health and Medical Research Fund 2022
Funding Year
2022
Status
On-going
Objectives
Metabolic-dysfunction associated fatty liver disease (MAFLD) is a new nomenclature introduced in 2020, and prospective outcome studies evaluating its health impact are still limited. We aim to investigate an updated incidence and fibrosis progression rate of MAFLD, as well as the risks of developing extra-hepatic outcomes, as compared to non-alcoholic fatty liver disease (NAFLD).